NasdaqGM - Delayed Quote USD

VanEck Pharmaceutical ETF (PPH)

87.50
+0.62
+(0.71%)
At close: May 29 at 4:00:00 PM EDT
87.91
+0.41
+(0.47%)
After hours: May 29 at 5:17:17 PM EDT

Top 10 Holdings (60.97% of Total Assets)

SymbolCompany% Assets
Eli Lilly and Company 13.12%
Johnson & Johnson 6.46%
AbbVie Inc. 6.33%
Novartis AG 5.40%
Cencora, Inc. 5.32%
McKesson Corporation 5.14%
AstraZeneca PLC 4.91%
Sanofi 4.82%
Takeda Pharmaceutical Company Limited 4.77%
Haleon plc 4.70%

Sector Weightings

SectorPPH
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 100.15%
Bonds 0.00%

Equity Holdings

Price/Earnings 0.04
Price/Book 0.31
Price/Sales 0.82
Price/Cashflow 0.08
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

ETF Overview

Category Health
Fund Family VanEck
Net Assets 630.26M
YTD Daily Total Return 1.29%
Yield 1.90%
Legal Type Exchange Traded Fund

Related Tickers